Soluble cellular adhesion molecules in proliferative vitreoretinopathy and proliferative diabetic retinopathy.

PURPOSE To measure vitreous levels of soluble intercellular adhesion molecule-1 (sICAM-1) and soluble vascular cellular adhesion molecule-1 (sVCAM-1) in the eyes of patients with retinal detachment (RD) due to proliferative diabetic retinopathy (PDR) or proliferative vitreoretinopathy (PVR) and to determine whether the levels of these mediators correlated with clinical parameters of disease. METHODS Undiluted vitreous specimens were collected from 50 eyes of 48 patients undergoing vitrectomy for traction RD due to PDR (21 specimens) and recurrent RD due to PVR (19 specimens). Control vitreous specimens were obtained from patients undergoing macular hole repair (10 specimens). The levels of sICAM-1 and sVCAM-1 were measured in each sample by specific enzyme-linked immunoadsorbent assays. RESULTS Vitreous levels of sICAM-1 were significantly increased in vitreous specimens from both PVR (median +/- SD; 12.0 +/- 76.3 ng/ml; P < 0.01) and PDR (8.4 +/- 24.0 ng/ml; P < 0.01) when compared to vitreous from eyes with macular holes (0. 3 +/- 4.2 ng/ml). Vitreous levels of sVCAM-1 were significantly increased in both PVR (36.5 +/- 255.2 ng/ml; P < 0.001) and PDR (26. 2 +/- 93.5 ng/ml; P < 0.01) when compared to control vitreous (17.7 +/- 7.8 ng/ml). The vitreous levels of sICAM-1 were higher in cases of PDR which developed recurrent proliferative disease (P < 0.01) and recurrent RD (P = 0.01), whereas the levels of sICAM-1 in PVR and sVCAM-1 in PDR and PVR did not significantly correlate with these clinical parameters. CONCLUSIONS Soluble forms of ICAM-1 and VCAM-1 are increased in the vitreous cavity of patients with RD due to PDR or PVR, reflecting the inflammatory nature of these conditions and suggesting a possible role for these mediators in the pathogenesis of proliferative retinal disease. The vitreous levels of these sCAMs at the time of surgery may serve as a marker of inflammation, but their specific levels do not predict the likelihood of recurrent proliferation or surgical anatomic success in most cases of PVR and PDR.

[1]  R. Machemer,et al.  The classification of retinal detachment with proliferative vitreoretinopathy. , 1983, Ophthalmology.

[2]  R. Rothlein,et al.  Induction of intercellular adhesion molecule 1 on primary and continuous cell lines by pro-inflammatory cytokines. Regulation by pharmacologic agents and neutralizing antibodies. , 1988, Journal of immunology.

[3]  A. Blann,et al.  Circulating Endothelial Cell/Leukocyte Adhesion Molecules in Atherosclerosis , 1994, Thrombosis and Haemostasis.

[4]  D. Wakefield,et al.  Distribution of lymphocytes and cell adhesion molecules in iris biopsy specimens from patients with uveitis. , 1992, Archives of ophthalmology.

[5]  W. Buurman,et al.  Current views on structure and function of endothelial adhesion molecules. , 1994, Cell adhesion and communication.

[6]  R. Tizard,et al.  Direct expression cloning of vascular cell adhesion molecule 1, a cytokine-induced endothelial protein that binds to lymphocytes , 1989, Cell.

[7]  Joan W. Miller,et al.  Vascular endothelial growth factor/vascular permeability factor is temporally and spatially correlated with ocular angiogenesis in a primate model. , 1994, The American journal of pathology.

[8]  A. Schmidt,et al.  Advanced glycation endproducts interacting with their endothelial receptor induce expression of vascular cell adhesion molecule-1 (VCAM-1) in cultured human endothelial cells and in mice. A potential mechanism for the accelerated vasculopathy of diabetes. , 1995, The Journal of clinical investigation.

[9]  Joan W. Miller,et al.  Increased vascular endothelial growth factor levels in the vitreous of eyes with proliferative diabetic retinopathy. , 1994, American journal of ophthalmology.

[10]  R. Nussenblatt,et al.  Expression of cell adhesion molecules in posterior uveitis. , 1992, Archives of ophthalmology.

[11]  A. Bellastella,et al.  Soluble intercellular adhesion molecule-1 (sICAM-1) concentrations in Graves' disease patients followed up for development of ophthalmopathy. , 1998, The Journal of clinical endocrinology and metabolism.

[12]  P. Polverini.  Cellular adhesion molecules. Newly identified mediators of angiogenesis. , 1996, The American journal of pathology.

[13]  M. Reddy,et al.  Elevated levels of soluble CD54 (ICAM‐1) in human immunodeficiency virus infection , 1993, Journal of clinical laboratory analysis.

[14]  G. A. Limb,et al.  Distribution of TNF alpha and its reactive vascular adhesion molecules in fibrovascular membranes of proliferative diabetic retinopathy. , 1996, The British journal of ophthalmology.

[15]  G. A. Limb,et al.  Vitreous intercellular adhesion molecule 1 in uveitis complicated by retinal detachment , 1998, The British journal of ophthalmology.

[16]  J. Olson,et al.  Soluble leucocyte adhesion molecules in diabetic retinopathy stimulate retinal capillary endothelial cell migration , 1997, Diabetologia.

[17]  H. Laqua,et al.  The vascular component of proliferative vitreoretinopathy membranes: an immunohistochemical and ultrastructural study. , 1998, Retina.

[18]  H. Yamashita,et al.  Population and proportion of component cells in preretinal membranes. , 1986, Japanese journal of ophthalmology.

[19]  K. Horgan,et al.  The LFA-1 ligand ICAM-1 provides an important costimulatory signal for T cell receptor-mediated activation of resting T cells. , 1990, Journal of immunology.

[20]  R. Kuijpers,et al.  Adhesion molecules in iris biopsy specimens from patients with uveitis , 1998, The British journal of ophthalmology.

[21]  P. Campochiaro,et al.  Ultrastructural and electron-immunocytochemical characterization of cells in epiretinal membranes. , 1990, Investigative ophthalmology & visual science.

[22]  C. Edelsten,et al.  Soluble intercellular adhesion molecule‐l (sICAM‐1) as a marker of disease relapse in idiopathic uveoretinitis , 1994, Clinical and experimental immunology.

[23]  L. Aiello,et al.  Vascular endothelial growth factor in ocular fluid of patients with diabetic retinopathy and other retinal disorders. , 1994, The New England journal of medicine.

[24]  P. Wiedemann.  Growth factors in retinal diseases: proliferative vitreoretinopathy, proliferative diabetic retinopathy, and retinal degeneration. , 1992, Survey of ophthalmology.

[25]  E. Lakatta,et al.  Elevated plasma levels of vascular cell adhesion molecule‐1 (VCAM‐1) in diabetic patients with microalbuminuria: a marker of vascular dysfunction and progressive vascular disease , 1996, British journal of haematology.

[26]  R. Nussenblatt,et al.  Monoclonal antibodies against CD54 (ICAM-1) and CD11a (LFA-1) prevent and inhibit endotoxin-induced uveitis. , 1995, Experimental eye research.

[27]  A. Koch,et al.  Soluble forms of P-selectin and intercellular adhesion molecule-3 in synovial fluids. , 1996, Clinical immunology and immunopathology.

[28]  C. Ballantyne,et al.  Levels of Soluble Cell Adhesion Molecules in Patients With Dyslipidemia , 1996 .

[29]  Joan W. Miller,et al.  Vascular endothelial growth factor is sufficient to produce iris neovascularization and neovascular glaucoma in a nonhuman primate. , 1996, Archives of ophthalmology.

[30]  A. Koch,et al.  Angiogenesis mediated by soluble forms of E-selectin and vascular cell adhesion molecule-1 , 1995, Nature.

[31]  S. Hawkins,et al.  Serum and cerebrospinal fluid levels of soluble adhesion molecules in multiple sclerosis: predominant intrathecal release of vascular cell adhesion molecule-1 , 1996, Journal of Neuroimmunology.

[32]  J. Trowsdale,et al.  Cotransfection of ICAM-1 and HLA-DR reconstitutes human antigen-presenting cell function in mouse L cells , 1989, Nature.

[33]  B. Kirchhof,et al.  Pathogenesis of Proliferative Vitreoretinopathy , 1989 .

[34]  V P Gabel,et al.  Expression of intercellular adhesion molecule-1 (ICAM-1) and vascular cell adhesion molecule-1 (VCAM-1) on proliferating vascular endothelial cells in diabetic epiretinal membranes. , 1994, The British journal of ophthalmology.

[35]  G. A. Limb,et al.  Intercellular adhesion molecule-1 in proliferative vitreoretinopathy. , 1997, Investigative ophthalmology & visual science.

[36]  S. Ryan.  Traction retinal detachment. XLIX Edward Jackson Memorial Lecture. , 1993, American journal of ophthalmology.

[37]  P. Selby,et al.  Circulating intercellular adhesion molecule-1 (ICAM-1), E-selectin and vascular cell adhesion molecule-1 (VCAM-1) in human malignancies. , 1993, British Journal of Cancer.

[38]  C. Gordon,et al.  Correlation of blood levels of soluble vascular cell adhesion molecule-1 with disease activity in systemic lupus erythematosus and vasculitis. , 1994, British journal of rheumatology.

[39]  P. Wiedemann,et al.  Intercellular adhesion molecule-1 levels in plasma and vitreous from patients with vitreoretinal disorders. , 1995, German journal of ophthalmology.

[40]  A. Boyd,et al.  Intercellular adhesion molecule 1 (ICAM-1) has a central role in cell-cell contact-mediated immune mechanisms. , 1988, Proceedings of the National Academy of Sciences of the United States of America.

[41]  V P Gabel,et al.  Proliferation and activation of vascular endothelial cells in epiretinal membranes from patients with proliferative diabetic retinopathy. An immunohistochemistry and clinical study. , 1994, German journal of ophthalmology.

[42]  A. Gearing,et al.  Soluble forms of E-selectin, ICAM-1 and VCAM-1 are present in the supernatants of cytokine activated cultured endothelial cells. , 1992, Biochemical and biophysical research communications.

[43]  C. Chan,et al.  Blocking both E-selectin and P-selectin inhibits endotoxin-induced leukocyte infiltration into the eye. , 1997, Clinical immunology and immunopathology.

[44]  A. Gearing,et al.  Circulating adhesion molecules in disease. , 1993, Immunology today.

[45]  N. Hogg,et al.  The function of human intercellular adhesion molecule‐1 (ICAM‐1) in the generation of an immune response , 1988, European journal of immunology.

[46]  J. Forrester,et al.  The role of growth factors in proliferative diabetic retinopathy , 1993, Eye.

[47]  T. Aaberg,et al.  AN UPDATED CLASSIFICATION OF RETINAL DETACHMENT WITH PROLIFERATIVE VITREORETINOPATHY , 1991 .